Subscribe
Log In
Corporate
DONATE

LinkedIn
X

Policy
Companies
Research
People
AI

Latest news

May 1, 2026 | Valneva shores up balance sheet after mixed trial results
April 30, 2026 | Novartis’ malaria drug for newborns cleared by WHO
April 29, 2026 | Outbreaks top AI concern – priority-setting report
March 9, 2026 | Real-time data on global dengue outbreaks
November 5, 2025 | Davos brain health plan hopes to unlock Africa funds

Search for:

Home Novartis

Novartis

Coartem Baby was developed by Novartis with scientific and financial support from the Medicines for Malaria Venture. Image from flickr, courtesy of World Bank

Medicines April 30, 2026

Novartis’ malaria drug for newborns cleared by WHO

The first malaria drug has received WHO prequalification for newborns

Most popular

US aid suspension threatens mpox fight
Uganda launches largest-ever malaria vaccine drive
Africa could miss out in a pandemic – study
World off-track to meet health SDGs – WHO
South Africa to make Gilead’s lenacapavir a ‘public good’

Privacy Policy
Account
About us

Copyright 2026 | MH Newsdesk by MH Themes

Please leave this field empty

Receive our fortnightly briefing on AI in global health

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.